Aura Renewable Acquisitions Plc
("Aura" or the "Company")
| 2 April 2025
|
| This announcement contains inside information for the purposes of Article 7 of the EU Market Abuse Regulation No. 596/2014/EU, which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018, as amended. Upon release via a Regulatory Information Service, this information is in the public domain.
|
| Not for release, publication or distribution in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
|
| Amendment of the rights of Warrants
|
| The Company is pleased to confirm that the amendments described in the announcement released by the Company on 28 March 2025 to the following Warrants have been completed on today's date, 2 April 2025, the requisite approvals of each class of Warrant holders having been obtained:
|
| 10,500,000 Aura Freely Transferable Warrants 2022; |
| 180,000 Aura Broker Warrants 2022; |
| 1,050,000 Aura Directors' Warrants 2022; and |
| 1,050,000 Aura Founder Warrants 2022. |
| |
| Conformed copies of the amended Warrant instruments will be available for viewing on the Company's website at https://aurarenewables.com.
|
| - Ends -
|
|
|
| Contact Information |
| Aura Renewable Acquisitions Plc
|
| John Croft, Chairman: +44 77 8531 5588
|
| LEI: 894500XA241IB9HL7147 |
| |
| This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
|
| RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
|
| END |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.